Advanced Filters
noise

Celiac Disease Clinical Trials

A listing of Celiac Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 1,232 clinical trials
E Edward Melanson, Ph.D.

Thermogenenic Responses to Fasting and Overfeeding in Women

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increases the risk …

18 - 65 years of age Female Phase N/A
S Saroja Voruganti, PHD

Concentration of n-3 PUFA Monohydroxylated Derivatives in Male Adults With Obesity After n-3 PUFA Supplementation.

The goal of this clinical trial is to learn if daily supplementation with SPM Active® can increase omega 3 polyunsaturated fatty acid derivatives and improve well-being in male adults with obesity. The main questions it aims to answer are: Does 2 g/day of SPM Active® for 12 weeks increase plasma …

45 - 60 years of age Male Phase N/A
S Sylvia Santosa, PhD

Effect of Acute ObeEnd Exposure on Factors Regulating Appetite

n Canada, over 60% of adults are classified as overweight and obese resulting in a public health crisis including increasing health care costs and negatively impacting the well-being of many Canadians. To overcome these barriers, the ObeEnd device, manufactured by WAT Medical Enterprise, is a new and innovative wellness technology …

18 - 60 years of age All Phase N/A

A Study of a Novel Precision Medicine Approach for Obesity

This study is being done to assess the efficacy of a saliva- based biomarker to predict response to semaglutide for the treatment of obesity.

18 - 65 years of age All Phase 4

Clinical Feasibility Study of the BariTon™ System in Obese Patients

Safety evaluation of BariaTek Medical gastric restriction and biliodigestive diversion device.

25 - 60 years of age All Phase N/A
K Kristen Gonzales, MD

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is the most common cause of chronic liver disease worldwide and predominately affects individuals with overweight and obesity, as well as those with type 2 diabetes and cardiovascular disease. Tirzepatide is a medication used to treat type 2 diabetes and obesity. It has also …

18 - 75 years of age All Phase N/A
J Juan L GCP Director

Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity

This study is a multicenter, randomized, partially double-blind (double-blind in both the IBI362 group and the placebo group, with the tirbopeptide group open), placebo and active drug controlled design study

18 - 55 years of age All Phase 1/2

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

In this study we will investigate how the medicine cagrilintide affects bone health in women after menopause with obesity during weight loss, compared to treatment with placebo (the dummy medicine with no active substances) and semaglutide. The purpose is to examine whether cagrilintide can reduce the decline in bone mass …

50 - 70 years of age Female Phase 1
M Megan Schaefer

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

The purpose of this study is to develop an evidence-based precision medicine approach for obesity that enhances weight loss and promotes weight loss maintenance.

18 - 65 years of age All Phase 4
B Barbara Ukropcova, Prof.

DIGITALIZATION OF PERSONALISED HEALTH RISK MANAGEMENT

The principal objective of the project is: to bring together academic and business research organisations in a joint partnership integrating technological and social innovation, in order to develop proof-of-concept of a scalable and cost effective personalised digital health program for (pre)obesity patients, by integrating, in an ethical manner, adaptive AI …

25 - 65 years of age All Phase N/A

Simplify language using AI